About DDB1- and CUL4-associated factor 13
DDB1- and CUL4-associated factor 13 (DCAF13) is a protein
from Homo sapiens identified by UniProt accession
Q9NV06, 445 residues long.
MolForge cross-references it against 0 known binders and
23 disease associations.
Target properties
| Protein name | DDB1- and CUL4-associated factor 13 |
| UniProt accession | Q9NV06 |
| Gene | DCAF13 |
| Organism | Homo sapiens |
| Length | 445 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (23)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.29
- erythrocyte count · score 0.20
- lung adenocarcinoma · score 0.08
- red blood cell density measurement · score 0.06
- neoplasm · score 0.05
- Mantle cell lymphoma · score 0.03
- cancer · score 0.03
- triple-negative breast cancer · score 0.03
- hepatocellular carcinoma · score 0.03
- head and neck squamous cell carcinoma · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NV06-F1 | alphafold | PREDICTED | 92.77 | — |
Amino-acid sequence (445 residues)
MKVKMLSRNP DNYVRETKLD LQRVPRNYDP ALHPFEVPRE YIRALNATKL ERVFAKPFLA SLDGHRDGVN CLAKHPEKLA TVLSGACDGE VRIWNLTQRN CIRTIQAHEG FVRGICTRFC GTSFFTVGDD KTVKQWKMDG PGYGDEEEPL HTILGKTVYT GIDHHWKEAV FATCGQQVDI WDEQRTNPIC SMTWGFDSIS SVKFNPIETF LLGSCASDRN IVLYDMRQAT PLKKVILDMR TNTICWNPME AFIFTAANED YNLYTFDMRA LDTPVMVHMD HVSAVLDVDY SPTGKEFVSA SFDKSIRIFP VDKSRSREVY HTKRMQHVIC VKWTSDSKYI MCGSDEMNIR LWKANASEKL GVLTSREKAA KDYNQKLKEK FQHYPHIKRI ARHRHLPKSI YSQIQEQRIM KEARRRKEVN RIKHSKPGSV PLVSEKKKHV VAVVK
Explore DDB1- and CUL4-associated factor 13 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets